Literature DB >> 21923917

Biobank resources for future patient care: developments, principles and concepts.

Akos Végvári1, Charlotte Welinder, Henrik Lindberg, Thomas E Fehniger, György Marko-Varga.   

Abstract

The aim of the overview is to give a perspective of global biobank development is given in a view of positioning biobanking as a key resource for healthcare to identify new potential markers that can be used in patient diagnosis and complement the targeted personalized drug treatment. The fast progression of biobanks around the world is becoming an important resource for society where the patient benefit is in the focus, with a high degree of personal integrity and ethical standard. Biobanks are providing patient benefits by large scale screening studies, generating large database repositories. It is envisioned by all participating stakeholders that the biobank initiatives will become the future gateway to discover new frontiers within life science and patient care. There is a great importance of biobank establishment globally, as biobanks has been identified as a key area for development in order to speed up the discovery and development of new drugs and protein biomarker diagnostics. One of the major objectives in Europe is to establish concerted actions, where biobank networks are being developed in order to combine and have the opportunity to share and build new science and understanding from complex disease biology. These networks are currently building bridges to facilitate the establishments of best practice and standardizations.

Entities:  

Year:  2011        PMID: 21923917      PMCID: PMC3197484          DOI: 10.1186/2043-9113-1-24

Source DB:  PubMed          Journal:  J Clin Bioinforma        ISSN: 2043-9113


  46 in total

Review 1.  How industry is approaching the search for new diagnostic markers and biomarkers.

Authors:  J Werner Zolg; Hanno Langen
Journal:  Mol Cell Proteomics       Date:  2004-01-28       Impact factor: 5.911

2.  Multiple personal genomes await.

Authors:  J Craig Venter
Journal:  Nature       Date:  2010-04-01       Impact factor: 49.962

Review 3.  On the development of plasma protein biomarkers.

Authors:  Silvia Surinova; Ralph Schiess; Ruth Hüttenhain; Ferdinando Cerciello; Bernd Wollscheid; Ruedi Aebersold
Journal:  J Proteome Res       Date:  2010-12-13       Impact factor: 4.466

4.  A clinician view and experience of proteomic studies in the light of lung cancer in Japanese healthcare.

Authors:  Harubumi Kato; Toshihide Nishimura; Takashi Hirano; Masaharu Nomura; Hiromasa Tojo; Kiyonaga Fujii; Takeshi Kawamura; Sayaka Mikami; Makoto Kihara; Yasuhiko Bando; Masahiro Tsuboi; Norihiko Ikeda; Gyorgy Marko-Varga
Journal:  J Proteome Res       Date:  2011-01-07       Impact factor: 4.466

5.  Towards a proteome-scale map of the human protein-protein interaction network.

Authors:  Jean-François Rual; Kavitha Venkatesan; Tong Hao; Tomoko Hirozane-Kishikawa; Amélie Dricot; Ning Li; Gabriel F Berriz; Francis D Gibbons; Matija Dreze; Nono Ayivi-Guedehoussou; Niels Klitgord; Christophe Simon; Mike Boxem; Stuart Milstein; Jennifer Rosenberg; Debra S Goldberg; Lan V Zhang; Sharyl L Wong; Giovanni Franklin; Siming Li; Joanna S Albala; Janghoo Lim; Carlene Fraughton; Estelle Llamosas; Sebiha Cevik; Camille Bex; Philippe Lamesch; Robert S Sikorski; Jean Vandenhaute; Huda Y Zoghbi; Alex Smolyar; Stephanie Bosak; Reynaldo Sequerra; Lynn Doucette-Stamm; Michael E Cusick; David E Hill; Frederick P Roth; Marc Vidal
Journal:  Nature       Date:  2005-09-28       Impact factor: 49.962

6.  The human disease network.

Authors:  Kwang-Il Goh; Michael E Cusick; David Valle; Barton Childs; Marc Vidal; Albert-László Barabási
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

Review 7.  A human proteome detection and quantitation project.

Authors:  N Leigh Anderson; Norman G Anderson; Terry W Pearson; Christoph H Borchers; Amanda G Paulovich; Scott D Patterson; Michael Gillette; Ruedi Aebersold; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2009-01-07       Impact factor: 5.911

8.  Isotope labeled internal standards (ILIS) as a basis for quality control in clinical studies using plasma samples.

Authors:  Melinda Rezeli; Akos Végvári; György Marko-Varga; Thomas Laurell
Journal:  J Proteomics       Date:  2010-02-20       Impact factor: 4.044

9.  Mass spectrometric protein identification using the global proteome machine.

Authors:  David Fenyö; Jan Eriksson; Ronald Beavis
Journal:  Methods Mol Biol       Date:  2010

10.  Ongoing and future developments at the Universal Protein Resource.

Authors: 
Journal:  Nucleic Acids Res       Date:  2010-11-04       Impact factor: 16.971

View more
  14 in total

1.  Linkage of data from diverse data sources (LDS): a data combination model provides clinical data of corresponding specimens in biobanking information system.

Authors:  Okyaz Eminaga; Enver Özgür; Axel Semjonow; Jan Herden; Ilgar Akbarov; Ali Tok; Udo Engelmann; Sebastian Wille
Journal:  J Med Syst       Date:  2013-09-11       Impact factor: 4.460

2.  Generation and validation of a universal perinatal database and biospecimen repository: PeriBank.

Authors:  K M Antony; P Hemarajata; J Chen; J Morris; C Cook; D Masalas; M Gedminas; A Brown; J Versalovic; K Aagaard
Journal:  J Perinatol       Date:  2016-09-15       Impact factor: 2.521

3.  The "North German Tumor Bank of Colorectal Cancer": status report after the first 2 years of support by the German Cancer Aid Foundation.

Authors:  Martina Oberländer; Michael Linnebacher; Alexandra König; Valentina Bogoevska; Christiane Brodersen; Regina Kaatz; Mathias Krohn; Michael Hackmann; Josef Ingenerf; Jan Christoph; Sebastian Mate; Hans-Ulrich Prokosch; Emre F Yekebas; Christoph Thorns; Jürgen Büning; Friedrich Prall; Ria Uhlig; Uwe J Roblick; Jakob R Izbicki; Ernst Klar; Hans-Peter Bruch; Brigitte Vollmar; Jens K Habermann
Journal:  Langenbecks Arch Surg       Date:  2013-01-08       Impact factor: 3.445

4.  Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area.

Authors:  Marco Tognetti; Kamil Sklodowski; Sebastian Müller; Dominique Kamber; Jan Muntel; Roland Bruderer; Lukas Reiter
Journal:  J Proteome Res       Date:  2022-05-23       Impact factor: 5.370

Review 5.  Collaborative cancer epidemiology in the 21st century: the model of cancer consortia.

Authors:  Michael R Burgio; John P A Ioannidis; Brett M Kaminski; Eric Derycke; Scott Rogers; Muin J Khoury; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

Review 6.  Precision health in Taiwan: A data-driven diagnostic platform for the future of disease prevention.

Authors:  Wesley Wei-Wen Hsiao; Jui-Chu Lin; Chien-Te Fan; Saint Shiou-Sheng Chen
Journal:  Comput Struct Biotechnol J       Date:  2022-03-26       Impact factor: 6.155

Review 7.  Nitrogen biobank for cardiovascular research.

Authors:  Antonella Mercuri; Stefano Turchi; Andrea Borghini; Maria Rosa Chiesa; Guido Lazzerini; Laura Musacchio; Ottavio Zirilli; Maria Grazia Andreassi
Journal:  Curr Cardiol Rev       Date:  2013-08

8.  The biorepository portal toolkit: an honest brokered, modular service oriented software tool set for biospecimen-driven translational research.

Authors:  Alex S Felmeister; Aaron J Masino; Tyler J Rivera; Adam C Resnick; Jeffrey W Pennington
Journal:  BMC Genomics       Date:  2016-08-18       Impact factor: 3.969

9.  BioBanking as the central tool for translational medicine CTM issue 2013.

Authors:  György Marko-Varga
Journal:  Clin Transl Med       Date:  2013-02-06

10.  The international effort: building the bridge for Translational Medicine: Report of the 1st International Conference of Translational Medicine (ICTM).

Authors:  Xiaoming Chen; Roland Andersson; William Cs Cho; David Christiani; Richard Coico; Jeffery Drazen; Markus Ege; Thomas Fehniger; Hongwei Gao; Kunlin Jin; Michael N Liebman; Elena Lopez; Giuseppe Marraro; Gyorgy Marko-Varga; Francesco M Marincola; Laurentiu M Popescu; Claudio Spada; Aamir Shahzad; Ena Wang; Wei Wang; Xiangdong Wang; Yong-Xiao Wang; Jinglin Xia; Jia Qu
Journal:  Clin Transl Med       Date:  2012-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.